v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 207,346 $ 279,572
Short-term investments 83,170 47,745
Restricted cash 2,766 0
Accounts Receivable 2,393 1,078
Inventories 1,369 1,098
Note receivable 0 32,005
Deferred offering costs 2,964 1,782
Prepaid expenses and other current assets 8,732 4,949
Current assets of discontinued operations 0 31,690
Total current assets 308,740 399,919
Property and equipment, net 91,795 33,291
Natural gas properties 130,222 0
Operating lease right-of-use assets, net 2,868 1,464
Deferred tax assets 72 0
Intangible assets 675 409
Goodwill 6,394 5,177
Lease receivable - noncurrent 3,908 426
Restricted cash 1,632 0
Equity method investments 24,855 0
Other investments 15,580 5,580
Other noncurrent assets 928 866
Noncurrent assets of discontinued operations 0 50,888
Total assets 587,669 498,020
Current liabilities:    
Accounts payable 6,868 3,814
Accrued expenses 7,897 4,414
Debt - current 53,265 584
Finance lease liabilities - current 165 167
Operating lease liabilities - current 789 544
Deferred revenue 882 882
Other current liabilities 501 501
Current liabilities of discontinued operations 0 21,790
Total current liabilities 70,367 32,696
Deferred tax liabilities 5,980 0
Convertible notes payable, at fair value 199,891 199,323
Debt - noncurrent 5,060 1,471
Finance lease liabilities - noncurrent 413 471
Operating lease liabilities - noncurrent 2,254 1,059
Deferred revenue - noncurrent 820 0
Other noncurrent liabilities 3,867 0
Noncurrent liabilities of discontinued operations 0 102
Total liabilities 288,652 235,122
Commitments and contingencies (Note 11)
Stockholders' equity    
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and December 31, 2025 0 0
Common stock, $0.01 par value; 500,000,000 shares authorized, 125,947,771 shares issued and 125,903,447 shares outstanding as of March 31, 2026 and 111,677,771 shares issued and outstanding as of December 31, 2025 1,259 1,117
Treasury stock at cost 0 0
Additional paid-in capital 528,924 431,757
Accumulated deficit (238,523) (231,265)
Accumulated other comprehensive (loss) income (2,659) 2,542
Total stockholders' equity attributed to ASP Isotopes Inc. stockholders 289,001 204,151
Noncontrolling interests in consolidated subsidiaries 10,016 58,747
Total stockholders' equity 299,017 262,898
Total liabilities and stockholders' equity $ 587,669 $ 498,020